Exact Sciences
EXAS
#1732
Rank
C$13.64 B
Marketcap
$73.75
Share price
-0.30%
Change (1 day)
-18.10%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.14

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.21. In 2022 the company made an earnings per share (EPS) of -$4.93 a decrease over its 2021 EPS that were of -$4.82.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.14-56.73%
2022-$4.932.31%
2021-$4.82-37.09%
2020-$7.67674.65%
2019-$0.99-50.69%
2018-$2.0144%
2017-$1.39-39.39%
2016-$2.30-2.94%
2015-$2.3737.1%
2014-$1.7379.71%
2013-$0.96-21.59%
2012-$1.2362.96%
2011-$0.7592.86%
2010-$0.39-3.45%
2009-$0.40-19.44%
2008-$0.50-18.18%
2007-$0.61-10.2%
2006-$0.68-10.91%
2005-$0.77-24.66%
2004-$1.02-51.33%
2003-$2.09-7.41%
2002-$2.2611.72%
2001-$2.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.24 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.47-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.56-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$70.95 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.43-300.57%๐Ÿ‡ซ๐Ÿ‡ท France